LFWD Stock Overview
A medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Lifeward Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.49 |
| 52 Week High | US$9.10 |
| 52 Week Low | US$1.41 |
| Beta | 2.07 |
| 1 Month Change | -19.02% |
| 3 Month Change | -52.40% |
| 1 Year Change | -69.24% |
| 3 Year Change | -84.23% |
| 5 Year Change | -90.28% |
| Change since IPO | -99.97% |
Recent News & Updates
Not Many Are Piling Into Lifeward Ltd. (NASDAQ:LFWD) Stock Yet As It Plummets 25%
Oct 30
Here's Why Lifeward (NASDAQ:LFWD) Must Use Its Cash Wisely
Oct 15Recent updates
Not Many Are Piling Into Lifeward Ltd. (NASDAQ:LFWD) Stock Yet As It Plummets 25%
Oct 30Here's Why Lifeward (NASDAQ:LFWD) Must Use Its Cash Wisely
Oct 15ReWalk Robotics Ltd. (NASDAQ:LFWD) Soars 26% But It's A Story Of Risk Vs Reward
Aug 01Is ReWalk Robotics (NASDAQ:LFWD) In A Good Position To Deliver On Growth Plans?
May 30Investors Give ReWalk Robotics Ltd. (NASDAQ:LFWD) Shares A 28% Hiding
Mar 14We Think ReWalk Robotics (NASDAQ:RWLK) Needs To Drive Business Growth Carefully
Jan 09Shareholders May Be A Bit More Conservative With ReWalk Robotics Ltd.'s (NASDAQ:RWLK) CEO Compensation For Now
Sep 06Is ReWalk Robotics (NASDAQ:RWLK) In A Good Position To Deliver On Growth Plans?
Jul 04Is ReWalk Robotics (NASDAQ:RWLK) In A Good Position To Invest In Growth?
Mar 07Here's Why We're Not Too Worried About ReWalk Robotics' (NASDAQ:RWLK) Cash Burn Situation
Oct 04ReWalk Robotics gets a new CFO
Sep 08ReWalK Q2 2022 Earnings Preview
Aug 08ReWalk Robotics receives Israeli court approval for $8M stock buyback
Jul 21ReWalk Robotics (NASDAQ:RWLK) Is In A Good Position To Deliver On Growth Plans
May 11ReWalk Robotics: Catalysts On The Horizon
Mar 09Here's Why We're Not Too Worried About ReWalk Robotics' (NASDAQ:RWLK) Cash Burn Situation
Jan 24ReWalk Robotics: Getting All Non-Cash Assets For Free
Nov 24We're Hopeful That ReWalk Robotics (NASDAQ:RWLK) Will Use Its Cash Wisely
Jun 22ReWalk Robotics: Plenty Of Runway To Re-Establish Growth
Jun 15We Think ReWalk Robotics (NASDAQ:RWLK) Can Afford To Drive Business Growth
Mar 08Shareholder Returns
| LFWD | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -12.6% | -3.4% | -3.5% |
| 1Y | -69.2% | 9.0% | 22.1% |
Return vs Industry: LFWD underperformed the US Medical Equipment industry which returned 11.2% over the past year.
Return vs Market: LFWD underperformed the US Market which returned 24% over the past year.
Price Volatility
| LFWD volatility | |
|---|---|
| LFWD Average Weekly Movement | 9.5% |
| Medical Equipment Industry Average Movement | 7.8% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 17.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: LFWD has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: LFWD's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 108 | Larry Jasinski | golifeward.com |
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors.
Lifeward Ltd. Fundamentals Summary
| LFWD fundamental statistics | |
|---|---|
| Market cap | US$13.21m |
| Earnings (TTM) | -US$19.30m |
| Revenue (TTM) | US$25.00m |
0.5x
P/S Ratio-0.7x
P/E RatioIs LFWD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LFWD income statement (TTM) | |
|---|---|
| Revenue | US$25.00m |
| Cost of Revenue | US$16.19m |
| Gross Profit | US$8.82m |
| Other Expenses | US$28.12m |
| Earnings | -US$19.30m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.19 |
| Gross Margin | 35.26% |
| Net Profit Margin | -77.21% |
| Debt/Equity Ratio | 0% |
How did LFWD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 13:29 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Lifeward Ltd. is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matthew Taylor | Barclays |
| William Plovanic | Canaccord Genuity |
| Swayampakula Ramakanth | H.C. Wainwright & Co. |